Cargando…
Pazopanib in the Treatment of Bone Sarcomas: Clinical Experience()
BACKGROUND: The effect of chemotherapy in metastatic bone sarcomas is poor and the condition is invariably fatal. Therefore, new treatment modalities are intensely needed. Pazopanib is a selective multitargeted tyrosine kinase inhibitor that has proven to be effective in the treatment of metastatic...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Neoplasia Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6931211/ https://www.ncbi.nlm.nih.gov/pubmed/31875575 http://dx.doi.org/10.1016/j.tranon.2019.12.001 |